Aaron Bloomer's most recent trade in Exact Sciences Corp. was a trade of 38,715 Restricted Stock Units done . Disclosure was reported to the exchange on Dec. 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 38,715 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 38,715 | 52,338 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 24,384 | 59,571 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2025 | 24,384 | 4,395 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 17,151 | 35,187 (0%) | 0% | 101.8 | 1,746,315 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 101.82 per share. | 23 Dec 2025 | 10,803 | 48,768 (0%) | 0% | 101.8 | 1,099,961 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 12,904 | 38,715 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 12,904 | 19,340 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 11,566 | 0 | - | - | Restricted Stock Units | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2025 | 11,556 | 11,556 (0%) | 0% | 0 | Common Stock | |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.25 per share. | 15 Apr 2025 | 5,717 | 13,623 (0%) | 0% | 44.2 | 252,977 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 44.25 per share. | 15 Apr 2025 | 5,120 | 6,436 (0%) | 0% | 44.3 | 226,560 | Common Stock |
| Exact Sciences Corp | Aaron Bloomer | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 28,779 | 28,779 | - | - | Restricted Stock Units |